Bolivia

  • Our results
  • /
  • Latin America & the Caribbean
  • /
  • Bolivia

KEY RESULTS

 

83% treatment success rate for TB (2014)

Source: World Health Organization

 

    

15,400 counselling and testing encounters for HIV

Source: UNDP

Reported confirmed cases of Malaria

Source: World Health Organization

Project Summary

In Bolivia, UNDP in partnership with the Global Fund, led the Malaria-Free Bolivia project, which covers 36 municipalities (close to 600,000 people) accounting for more than 85% of the country’s malaria cases. Extending prevention services and treatment coverage to the country’s most endemic areas resulted in zero deaths from the disease reported for the past five years, as well as the achievement of MDG target of 2 deaths per 1000 people infected. In the past, UNDP managed Global Fund HIV and TB grants, supporting the integration of HIV counselling and testing into sexual and reproductive health services and helping to establish routine surveillance systems for all previously treated TB cases. In January 2017 UNDP and the Global Fund announced a new grant agreement to fight tuberculosis in Bolivia. The programme aims to strengthen detection, diagnosis and treatment and will focus on TB/HIV co-infections, drug resistant TB, and TB in Bolivian prison populations. The country’s 22 prisons and local jails are over-crowded and act as fertile ground for the spread of airborne diseases such as tuberculosis: the rate of increase of TB cases among the prison population is 11 times higher than in the rest of the population.

KEY RESULTS - CONTINUED

 

65% of HIV positive TB patients on antiretroviral therapy (2015)

Source: World Health Organization

76% women living with HIV on antiretroviral medicine to prevent mother to child transmission (2015)

Source: UNAIDS

55,200 cases of Malaria treated

Source: UNDP

TB incidence

Source: World Health Organization

Maternal and infant mortality rates

Source: World Health Organization

PORTFOLIO OVERVIEW

 

 

Disease Component

Malaria

Grant

BOL-M-UNDP

Phase

Period 1

Amount

                        $10,333,318

Rating

 

 

Disease Component

Tuberculosis

Grant

BOL-T-UNDP

Phase

Period 1

Amount

                        $10,710,756

Rating

  

 

 

Overall Grant Rating

 

 

  Exceeding expectations

 

  Meeting expectations

 

  Adequate

 

  Inadequate but potential demonstrated

 

  Unacceptable

 

  No rating available